AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression is a research paper published in Journal of Medical Virology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA222148
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: R21 CA226542
NCI NIH HHS
Grant: R33 CA258016
NCI NIH HHS
Grant: R21 CA180524
NCI NIH HHS
Grant: R33 CA177466
NIAID NIH HHS
Grant: R56 AI157872
NCI NIH HHS
Grant: R01 CA276474
NCI NIH HHS
Grant: R01 CA205632
National Institutes of Health
Grant: 1R21CA180524-01
NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPV
National Institutes of Health
Grant: 1R01CA222148-01A1
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
National Institutes of Health
Grant: 5R01CA205632-02
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
National Institutes of Health
Grant: 1R21CA226542-01A1
Development of clinically relevant models of DCIS
National Institutes of Health
Grant: 1R33CA177466-01
Conditionally reprogrammed cells as a novel tool for biobanking
National Institutes of Health
Grant: 5R33CA258016-02
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
Georgetown University
National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals